Share
Market Research Report

REMICADE BIOSIMILARS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypeInfliximab · Adalimumab · Etanercept · Others
  • By End UserHospitals · Specialty Clinics · Retail Pharmacies · Others
  • By IndicationRheumatoid Arthritis · Crohn’s Disease · Psoriasis · Ulcerative Colitis · Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In28 Apr 2026
  • Report CodeCMI1769
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Table of Contents

  1. Research Objectives and Assumptions

    • Research Objectives

    • Assumptions

    • Abbreviations

  2. Market Preview

    • Report Description

      • Market Definition and Scope

    • Executive Summary

      • Market Snapshot, By Product Type

      • Market Snapshot, By End User

      • Market Snapshot, By Indication

      • Market Snapshot, By Region

    • Coherent Opportunity Map (COM)

  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics

      • Drivers

      • Restraints

      • Market Opportunities

    • Impact Analysis

    • Recent Product Launches

    • Epidemiology

    • Merger, Acquisition, and Collaboration

    • Regulatory Scenario

    • Key Developments

    • PEST Analysis

    • Partnership Scenario

    • Brand and Pricing Analysis

    • Distributors Landscape

    • Porters Analysis

    • Technological Advancements

    • Key Developments

    • Market Trend

    • Future Prospective

    • Top Market Players by Revenue

  4. Remicade Biosimilars Market By Product Type, 2026–2033, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2026 and 2033 (%)

      • Y-o-Y Growth Analysis, 2022–2033

      • Segment Trends

    • Infliximab

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

    • Adalimumab

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

    • Etanercept

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

  5. Remicade Biosimilars Market By End User, 2026 - 2033, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2026 and 2033 (%)

      • Y-o-Y Growth Analysis, 2022–2033

      • Segment Trends

    • Hospitals

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

    • Specialty Clinics

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

    • Retail Pharmacies

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

  6. Remicade Biosimilars Market By Indication, 2026 - 2033, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2026 and 2033 (%)

      • Y-o-Y Growth Analysis, 2022–2033

      • Segment Trends

    • Rheumatoid Arthritis

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

    • Crohn’s Disease

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

    • Psoriasis

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

    • Ulcerative Colitis

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

  7. Remicade Biosimilars Market By Region, 2026 - 2033, (US$ Billion)

    • Introduction

      • Market Share Analysis, By Region, 2026 and 2033 (%)

      • Y-o-Y Growth Analysis, For Regions, 2022–2033

      • Regional Trends

    • North America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2026 - 2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)

        • U.S.

        • Canada

    • Latin America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2026 - 2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2026 - 2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)

        • U.K.

        • Germany

        • Italy

        • France

        • Spain

        • Russia

        • Benelux

        • Denmark

        • Norway

        • Sweden

        • Rest of Europe

    • Asia Pacific

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2026 - 2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)

        • China

        • Taiwan

        • India

        • Japan

        • Indonesia

        • Malaysia

        • Philippines

        • Singapore

        • Australia

        • South Korea

        • Rest of Asia Pacific

o Middle East & Africa

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2026 - 2033, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • UAE

    • Israel

    • South Africa

    • North Africa

    • Central Africa

    • Rest of the Middle East

  1. Competitive Landscape

    • Pfizer Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Samsung Bioepis

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Celltrion, Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Sandoz (a Novartis division)

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Biocon Ltd.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Amgen Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Mylan N.V.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Dr. Reddy’s Laboratories

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Zydus Cadila

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Intas Pharmaceuticals

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Lupin Ltd.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Teva Pharmaceuticals

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

  2. Section

    • Research Methodology

    • About Us